Suppliers / Shodhana Laboratories

Shodhana Laboratories

India 128 employees Updated 9 July 2026

Shodhana Laboratories is a contract manufacturer based in India. It holds 8 active US drug master files across a filed portfolio of 5 molecules. Its GMP standing is certified by MFDS (Korea). Customs aggregates show $9.6M of exports covering 214 molecules to 42 destinations in 2025.

8
active US DMFs
0
valid CEPs
2
registered plants 2 with an FDA FEI number
1
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
2 of 2 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
Hyderabad, India 3010836438
Visakhapatnam, India 3029445647

What they file, and where

Molecule Regulators Docs
Carvedilol SFDA (Saudi Arabia), US FDA 3
Escitalopram SFDA (Saudi Arabia), US FDA 3
Duloxetine US FDA 2
Rivastigmine US FDA 2
Ondansetron SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Carvedilol contract manufacturing Citalopram contract manufacturing Duloxetine contract manufacturing Escitalopram contract manufacturing Ondansetron contract manufacturing Rivastigmine contract manufacturing

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 1 None
MFDS (Korea) None 2

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $1.5M 19
2025 Not reported $9.6M 42
2024 Not reported $9.5M 37
2023 Not reported $6.9M 34

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Shodhana Laboratories

Does Shodhana Laboratories hold a US DMF or a CEP?
Shodhana Laboratories holds 8 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Shodhana Laboratories FDA-registered?
2 sites operated by Shodhana Laboratories carry an FDA establishment identifier (FEI), which means they are registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
Where does Shodhana Laboratories manufacture?
2 registered sites are on record, in India (Hyderabad and Visakhapatnam). Every site is listed on this page with the register it came from.
What does Shodhana Laboratories make?
5 molecules are on record against Shodhana Laboratories, including Carvedilol, Escitalopram, Duloxetine and Rivastigmine. Each links through to that molecule's full manufacturer list.
Which regulators recognise Shodhana Laboratories's GMP?
Current GMP certificates are on record from MFDS (Korea). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Shodhana Laboratories comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Apitoria Pharma shares 4 molecules Cipla shares 4 molecules Dr Reddy's Laboratories shares 4 molecules Zydus Lifesciences shares 3 molecules Macleods Pharmaceuticals shares 3 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts